In addition to his ArunA leadership responsibilities, Mr Sharp has also been appointed to ArunA’s board of directors. Mr Sharp succeeds ArunA founder Steven Stice, who will remain as ArunA’s chairman and chief scientific officer.
Most recently, Mr Sharp served as chief commercial officer of BioProcessors. Mr Sharp holds MS and BA degrees from The Pennsylvania State University.
Dr Stice said: “Bill has an extensive background leading life science businesses and his leadership is critical to the success of the company’s next phase of growth. Bill’s experience and expertise in the industry are key elements to further positioning ArunA as the industry leader in this emerging market.”